NCT07126821 A Vision-Language Foundation Model for Brain Disease Diagnosis From Multimodal Data
| NCT ID | NCT07126821 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xiangya Hospital of Central South University |
| Condition | Brain (Nervous System) Cancers |
| Study Type | OBSERVATIONAL |
| Enrollment | 100,000 participants |
| Start Date | 2025-05-15 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100,000 participants in total. It began in 2025-05-15 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to develop an innovative, comprehensive, and explainable AI vision-language foundation model (VLM) to advance the diagnosis and interpretation of brain diseases using multi-modal data. We will include patient demographics, medical imaging data (such as MRI, CT, and PET scans), histopathological data, genomic data when available, and other necessary laboratory examinations and tests to establish a screening and diagnostic model for brain diseases.
Eligibility Criteria
Inclusion Criteria: Patients with brain diseases: * Patients with brain tumors were pathologically diagnosed. * Patients with other brain diseases were correctly diagnosed. * The clinical case data of all patients were complete. Non-brain disease population: * All patients have complete clinical case data, complete brain MRI, no history brain diseases, no brain surgery or other brain diseases that affect the diagnosis and observation of MR imaging. Exclusion Criteria: * Cases in which MRI were incomplete or with significant noise and artifacts.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07126821 clinical trial?
This trial is open to participants of all sexes, studying Brain (Nervous System) Cancers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07126821 currently recruiting?
Yes, NCT07126821 is actively recruiting participants. Contact the research team at gong.xuan@csu.edu.cn for enrollment information.
Where is the NCT07126821 trial being conducted?
This trial is being conducted at Changsha, China.
Who is sponsoring the NCT07126821 clinical trial?
NCT07126821 is sponsored by Xiangya Hospital of Central South University. The trial plans to enroll 100,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.